OB/GYN Clinical Alert – December 1, 2006
December 1, 2006
View Issues
-
Magnesium Sulfate Tocolysis
In the vast majority of hospitals magnesium sulfate has been the drug of choice to stop labor in patients presenting with preterm contractions. -
Lower Doses of Estrogen Inhibit Atherosclerosis
Clarkson and colleagues report the results of a lower-dose estrogen trial in a monkey model of coronary atherosclerosis. The animals were fed an atherogenic diet for 10 months, calculated to induce atherosclerosis comparable to that observed in early postmenopausal women. -
Quality of Life After Tension-Free Vaginal Tape Obturator
The purported advantages of the tension-free vaginal tape obturator (TVT-O) procedure include avoidance of bowel damage, reduction in risk of bladder and major vessel damage, and elimination of the need for routine cystoscopic evaluation during insertion. -
Therapeutic Role of Lymph Node Resection in Endometrioid Corpus Cancer
The therapeutic role of lymphadenectomy in patients with endometrial cancer is controversial and challenging to study given the relative infrequency of metastatic disease and the generally good prognosis of newly diagnosed patients. Nevertheless, prior work in limited sized cohorts has suggested that the number of nodes resected may be prognostic and informative in planning subsequent adjuvant treatment. -
Survival Patterns after Oophorectomy in Premenopausal Women: A Population-Based Cohort Study
This study was made possible by the mayo Clinic Cohort Study of Oophorectomy and Aging, the main aim of which is to detect new cases of age-related diseases, especially Parkinson's disease and dementia. This report focused on the mortality outcomes. -
Depot Medroxyprogesterone Acetate and Weight Gain
Bonny and colleagues report the effect of depot medroxyprogesterone on weight changes in obese and nonobese adolescent girls. This was a prospective study of 450 adolescents, aged 12 to 18 years. -
Pharmacology Watch: Sweeping Changes Needed for US Drug Safety System
Antiaging Supplements Proven Ineffective; The Three Most Common Culprits of ADE; New Guidelines for Lyme Disease Prevention; FDA Actions -
Clinical Briefs in Primary Care supplement